A Systematic Review and Critical Assessment of Health State Utilities

Scott Doyle, Andrew Lloyd (), Lee Moore, Joshua Ray and Alastair Gray
Additional contact information
Scott Doyle: Oxford Outcomes
Andrew Lloyd: Oxford Outcomes
Lee Moore: Roche Products Ltd.
Joshua Ray: F. Hoffmann-La Roche Ltd.

PharmacoEconomics, 2012, vol. 30, issue 12, No 4, 1133-1143

Abstract: Abstract Objective The study aimed to conduct a systematic literature search to identify health state utilities for weight change in type 2 diabetes mellitus (T2DM) and to review those values for appropriateness for inclusion in a submission to the National Institute for Health and Clinical Excellence (NICE). Methods The search was conducted using keywords and Medical Subject Heading (MeSH) terms designed to exhaustively capture health state utility values across a variety of known economic, health technology assessment and peer-reviewed publication databases. The values were then critically reviewed from the perspective of the NICE reference case (2008 methods guide). Results The search resulted in a large number of repeat references across databases suggesting good sensitivity. Thirty-three articles were selected for inclusion and subjected to a critical review including their methodological quality, symmetry with the NICE reference case, sample size and country source. This critical review led to a shortlist of nine utility studies, all of which had potential for inclusion in cost-utility models or a meta-analysis. Conclusions A relatively large number of utilities have been collected in weight change and T2DM. Many of these utility values are not suitable for inclusion in a NICE submission. A better way of reviewing the methodological quality of utilities is needed.

Keywords: Health Technology Assessment; Rimonabant; Sibutramine; Evidence Review Group; Health State Utility (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.2165/11599420-000000000-00000 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
Journal Article: A Systematic Review and Critical Assessment of Health State Utilities (2012)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11599420-000000000-00000

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.2165/11599420-000000000-00000

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().